DCIS Score Fails Cost-Effectiveness Test DCIS Score Fails Cost-Effectiveness Test
The Oncotype DX DCIS Score was not cost-effective in any of five different treatment strategies that were analyzed.Medscape Medical News
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Hematology | Surgery